Value creation in life sciences – 22: Risk again
In this video we discuss several fundamental points about risks. One of them is that Risk is always in the future and many things that happened in the past may not happen tomorrow.
Posts Categorized: Blog
- Home
- Blog ( - Page 2)
Value creation in life sciences – 21: Musings
In this video, we discuss with Guillem, Partner at Ysios Capital about : Tacit knowledge, Scale and how Investors select a biotech/medtech company.
Value creation in life sciences – 20: Mimetic Desire
In this video we talk about Rene Girard’s mimetic desire and how having awareness of this can allow to navigate our desires better. Most importantly, we use these concepts to understand how a Biotech/Medtech CEO can make better decisions.
Value creation in life sciences – 19: Musings with Reto Naef
In this video, we will discuss with Reto Naef, how hard it was to raise $34 M as well as other interesting questions such as serendipity in Science etc.
Value creation in life sciences – 18: Risk (continued)
In this video we explain why men tend to forget objects and women don’t. Also, why we keep eating, leading to obesity epidemic. Last but not least, why understanding these has to do with Value creation.
Value creation in life sciences – 16: Risk
In this video we discuss why we humans do not understand risk. The genes that our ancestors carried are passed down to us , hence our brain is wired to solve ancient problems and not modern ones.
Value creation in life sciences – 17
In this video, we discuss with Jose, who served as the CEO of Alex Therapeutics and have vast experience in Biotech, about portfolio management and risk taking in the Biotech space. The questions we discuss are : Given the returns…
Value creation in life sciences – 15: Scale
In this video, we discuss scale by providing analogy to why humans don’t grow like HULK. Then we discuss what all companies can do to scale well.
Value creation in life sciences – 14
In this video we discuss with Stephan Christgau, Founding partner Eir Ventures about mainly three questions : 1. Serendipity in Life Sciences : How much happenstance play a role and how does he choose the team that has an open-minded…
Value creation in life sciences – 13
In this video we chat with Edoardo Negroni to understand his perspective on Value creation, scaling up and responsibility towards patients. Edoardo is the Co-Founder and Managing partner of AurorA Science, a biotech investment company which invests with the aim…